RT Journal Article
SR Electronic
T1 Do maternal intrauterine environmental influences that lower offspring birthweight causally increase offspring cardiometabolic risk factors in later life? A Mendelian randomization study of 45,849 genotyped parent offspring pairs in the HUNT study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.04.20091173
DO 10.1101/2020.05.04.20091173
A1 Moen, Gunn-Helen
A1 Brumpton, Ben
A1 Willer, Cristen
A1 Åsvold, Bjørn Olav
A1 Birkeland, Kåre
A1 Neale, Michael C
A1 Freathy, Rachel M
A1 Smith, George Davey
A1 Lawlor, Deborah A
A1 Kirkpatrick, Robert M
A1 Warrington, Nicole M
A1 Evans, David M
YR 2020
UL http://medrxiv.org/content/early/2020/05/08/2020.05.04.20091173.abstract
AB Introduction There is a robust and well-documented observational relationship between lower birthweight and higher risk of cardiometabolic disease in later life. The Developmental Origins of Health and Disease (DOHaD) hypothesis posits that adverse environmental factors in utero or in the early years of life result in increased future risk of cardiometabolic disease. Our aim was to investigate whether there was evidence for causal effects of the intrauterine environment, as proxied by maternal single nucleotide polymorphisms (SNPs) that influence offspring birthweight independent of offspring genotype, on offspring cardiometabolic risk factors such as blood pressure, non-fasting glucose, body mass index (BMI), and lipid levels.Methods We investigated whether a genetic risk score of maternal SNPs associated with offspring birthweight was also associated with offspring cardiometabolic risk factors, after controlling for offspring genotypes at the same loci, in up to 26,057 mother-offspring pairs from the Nord-Trøndelag Health (HUNT) Study. We also conducted similar analyses in 19,792 father-offspring pairs from the same study to investigate whether there was evidence that any such causal effects operated through the postnatal, rather than the intrauterine environment. To take account of the considerable cryptic relatedness in HUNT, we implemented a computationally efficient genetic linear mixed model using the OpenMx software package to perform our analyses.Results We found little evidence for a maternal genetic effect of birthweight associated variants on offspring cardiometabolic risk factors after adjusting for offspring genotypes at the same loci. Likewise, we found little evidence for paternal genetic effects on offspring cardiometabolic risk factors performing similar analyses in father-offspring pairs. In contrast, offspring genetic risk scores of birthweight associated variants were strongly related to many cardiometabolic risk factors, even after conditioning on maternal genotypes at the same loci.Conclusion Our results suggest that the maternal intrauterine environment, as proxied by maternal SNPs that influence offspring birthweight, is unlikely to be a major determinant of adverse cardiometabolic outcomes in population based samples of individuals. In contrast, genetic pleiotropy appears to explain some of the observational relationship between offspring birthweight and future cardiometabolic risk.Competing Interest StatementD.A.L. has received research support from several national and international government and charity funders, and from Medtronic Ltd and Roche Diagnostics in the last 10 years.Funding StatementThe genotyping in HUNT was financed by the National Institutes of Health (NIH); University of Michigan; The Research Council of Norway; The Liaison Committee for Education, Research and Innovation in Central Norway; and the Joint Research Committee between St. Olavs hospital and the Faculty of Medicine and Health Sciences, NTNU. The Translational Research Institute is supported by a grant from the Australian Government. Support for this research have been given by the Norwegian Diabetes Association and Nils Normans minnegave. G.H.M is supported by the Norwegian Research Council (Post doctorial mobility research grant 287198). N.M.W. is supported by an Australian National Health and Medical Research Council Early Career Fellowship (APP1104818). MCN and OpenMx development were funded by NIH grant DA-018673. D.A.L is supported by the British Heart Foundation (AA/18/7/34219) and European Research Council (669545). D.A.L, G.D.S, D.M.E are affiliated with a Unit that receives support from the University of Bristol and the UK Medical Research Council (MC_UU_00011/1 and MC_UU_00011/6). D.M.E. is funded by an Australian National Health and Medical Research Council Senior Research Fellowship (APP1137714) and NHMRC project grants (GNT1125200, GNT1157714, GNT1183074).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResearchers with a PhD associated with Norwegian research institutes can apply for the use of HUNT material: data and samples - given approval by a Regional Committee for Medical and Health Research Ethics. Researchers from other countries are welcome to apply in cooperation with a Norwegian Principle Investigator. https://www.ntnu.edu/hunt/data